{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Gurnee",
      "state": "IL",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "91580",
      "recalling_firm": "Akorn, Inc.",
      "address_1": "5605 Centerpoint Ct Ste A",
      "address_2": "",
      "postal_code": "60031-5278",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the USA and Puerto Rico",
      "recall_number": "D-0265-2023",
      "product_description": "Atropine Sulfate Ophthalmic Solution, USP 1%, For Topical Application To The Eye, 2 mL bottle, Sterile, Rx only, Distributed by: Akorn Operating Company LLC, Gurnee, IL 60031.  NDC: 17478-215-02",
      "product_quantity": "45,117 Bottles",
      "reason_for_recall": "Failed Stability Specifications: Out of specification test results for viscosity was identified at the 12M stability timepoint.",
      "recall_initiation_date": "20230130",
      "center_classification_date": "20230208",
      "report_date": "20230215",
      "code_info": "Lot: 081031A, Exp 2/28/2023",
      "more_code_info": ""
    }
  ]
}